基于对比增强T1 mapping的细胞外容积分数可独立预测非缺血性扩张型心肌病患者的临床结局:一项前瞻性队列研究
该单中心前瞻性队列研究纳入117例非缺血性扩张型心肌病患者,行3.0-T心脏磁共振检查,定量心肌细胞外容积分数(ECV)和晚期钆增强(LGE),随访中位11.2个月,19例(16.2%)发生心血管事件;ECV每增加3%和1%的风险比分别为1.80和1.22,多变量分析显示ECV为独立预后因素,Harrell's c统计量0.88高于LGE定量值0.77或壁中LGE 0.80。
要点
- ECV每增加3%,心血管事件风险比1.80(95%CI 1.48-2.20,p<0.001)。
- ECV每增加1%,风险比1.22(95%CI 1.14-1.30,p<0.001)。
- ECV的Harrell's c统计量0.88,高于LGE定量值0.77或壁中LGE 0.80。
核心结论
- 基于心脏磁共振的ECV可独立预测非缺血性扩张型心肌病患者的临床结局。
研究设计与样本
- 单中心前瞻性队列研究,纳入117例非缺血性扩张型心肌病患者(71例男性,年龄51.9±16.7岁),行临床3.0-T心脏磁共振检查,另设19例健康对照。
关键影像表现/征象
- 在左心室心肌上定量心肌ECV和LGE。
- 检测壁中LGE的存在。
诊断标准与关键数值
- 主要终点为心血管事件,包括心血管死亡、因心力衰竭再住院和心脏移植。
- 随访中位11.2个月(第25-75百分位7.8-21.9个月),19例(16.2%)发生主要终点事件。
- ECV每增加3%,心血管事件风险比1.80(95%CI 1.48-2.20,p<0.001)。
- ECV每增加1%,心血管事件风险比1.22(95%CI 1.14-1.30,p<0.001)。
- 多变量分析显示ECV为独立预后因素,Harrell's c统计量0.88,高于LGE定量值0.77或壁中LGE 0.80。
临床应用与阅片要点
- 作者结论认为基于心脏磁共振的ECV可独立预测非缺血性扩张型心肌病患者的临床结局。
- 作者要点指出基于T1 mapping的ECV是非缺血性扩张型心肌病风险分层的有用参数。
- 作者要点指出ECV的预后价值高于LGE。
- 作者要点指出对比增强T1 mapping心脏磁共振是可行且安全的方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: We aimed to evaluate the prognostic role of cardiac magnetic resonance imaging (CMR)-based extracellular volume fraction (ECV) in patients with non-ischemic dilated cardiomyopathy (NIDCM) and compare it with late gadolinium enhancement (LGE) parameters.
METHODS: This was a single-center, prospective, cohort study of 117 NIDCM patients (71 men, 51.9 ± 16.7 years) who underwent clinical 3.0-T CMR. Myocardial ECV and LGE were quantified on the left ventricular myocardium. The presence of midwall LGE was also detected. Nineteen healthy subjects served as controls. The primary end points were cardiovascular (CV) events defined by CV death, rehospitalization due to heart failure, and heart transplantation.
RESULTS: During the follow-up period (median duration, 11.2 months; 25th-75th percentile, 7.8-21.9 months), the primary end points occurred in 19 patients (16.2%). The ECV (per 3% and 1% increase) was associated with a hazard ratio of 1.80 and 1.22 (95% confidence interval [CI], 1.48-2.20 and 1.14-1.30, respectively; p < 0.001) for the CV events. Multivariable analysis also indicated that ECV was an independent prognostic factor and had a higher prognostic value (Harrell's c statistic, 0.88) than LGE quantification values (0.77) or midwall LGE (0.80).
CONCLUSION: CMR-based ECV independently predicts the clinical outcome in NIDCM patients.
KEY POINTS: • T1-mapping-based ECV is a useful parameter of risk stratification in NIDCM • ECV has a higher prognostic value than LGE • Contrast-enhanced T1-mapping CMR is a feasible and safe method.
引用
- Youn JC, Hong YJ, Lee HJ, et al. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study. Eur Radiol. 2017. PMID: 28439651. doi:10.1007/s00330-017-4817-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。